nodes	percent_of_prediction	percent_of_DWPC	metapath
Nadolol—ABCB1—peripheral nervous system neoplasm	0.537	1	CbGaD
Nadolol—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0607	0.239	CbGbCtD
Nadolol—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0607	0.239	CbGbCtD
Nadolol—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0421	0.166	CbGbCtD
Nadolol—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0259	0.102	CbGbCtD
Nadolol—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.0242	0.0953	CbGbCtD
Nadolol—ABCB1—Etoposide—peripheral nervous system neoplasm	0.0238	0.0937	CbGbCtD
Nadolol—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.0162	0.0639	CbGbCtD
Nadolol—Vision blurred—Alitretinoin—peripheral nervous system neoplasm	0.000359	0.00172	CcSEcCtD
Nadolol—Decreased appetite—Isotretinoin—peripheral nervous system neoplasm	0.000357	0.00171	CcSEcCtD
Nadolol—Decreased appetite—Tretinoin—peripheral nervous system neoplasm	0.000357	0.00171	CcSEcCtD
Nadolol—Fatigue—Topotecan—peripheral nervous system neoplasm	0.000357	0.0017	CcSEcCtD
Nadolol—Dyspepsia—Melphalan—peripheral nervous system neoplasm	0.000357	0.0017	CcSEcCtD
Nadolol—Agranulocytosis—Etoposide—peripheral nervous system neoplasm	0.000355	0.0017	CcSEcCtD
Nadolol—Fatigue—Isotretinoin—peripheral nervous system neoplasm	0.000354	0.00169	CcSEcCtD
Nadolol—Fatigue—Tretinoin—peripheral nervous system neoplasm	0.000354	0.00169	CcSEcCtD
Nadolol—Pain—Topotecan—peripheral nervous system neoplasm	0.000354	0.00169	CcSEcCtD
Nadolol—Constipation—Topotecan—peripheral nervous system neoplasm	0.000354	0.00169	CcSEcCtD
Nadolol—Dry eye—Epirubicin—peripheral nervous system neoplasm	0.000352	0.00168	CcSEcCtD
Nadolol—Decreased appetite—Melphalan—peripheral nervous system neoplasm	0.000352	0.00168	CcSEcCtD
Nadolol—Constipation—Tretinoin—peripheral nervous system neoplasm	0.000351	0.00168	CcSEcCtD
Nadolol—Pain—Tretinoin—peripheral nervous system neoplasm	0.000351	0.00168	CcSEcCtD
Nadolol—Pain—Isotretinoin—peripheral nervous system neoplasm	0.000351	0.00168	CcSEcCtD
Nadolol—Constipation—Isotretinoin—peripheral nervous system neoplasm	0.000351	0.00168	CcSEcCtD
Nadolol—Fatigue—Melphalan—peripheral nervous system neoplasm	0.000349	0.00167	CcSEcCtD
Nadolol—Tinnitus—Cisplatin—peripheral nervous system neoplasm	0.000348	0.00166	CcSEcCtD
Nadolol—Pain—Melphalan—peripheral nervous system neoplasm	0.000346	0.00166	CcSEcCtD
Nadolol—Syncope—Alitretinoin—peripheral nervous system neoplasm	0.000342	0.00163	CcSEcCtD
Nadolol—Pulmonary oedema—Epirubicin—peripheral nervous system neoplasm	0.000339	0.00162	CcSEcCtD
Nadolol—Oedema—Dactinomycin—peripheral nervous system neoplasm	0.000335	0.0016	CcSEcCtD
Nadolol—Fluid retention—Doxorubicin—peripheral nervous system neoplasm	0.000335	0.0016	CcSEcCtD
Nadolol—Loss of consciousness—Alitretinoin—peripheral nervous system neoplasm	0.000335	0.0016	CcSEcCtD
Nadolol—Cough—Alitretinoin—peripheral nervous system neoplasm	0.000332	0.00159	CcSEcCtD
Nadolol—Alopecia—Cisplatin—peripheral nervous system neoplasm	0.00033	0.00158	CcSEcCtD
Nadolol—Hypertension—Alitretinoin—peripheral nervous system neoplasm	0.000329	0.00157	CcSEcCtD
Nadolol—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.000327	0.00156	CcSEcCtD
Nadolol—Dry eye—Doxorubicin—peripheral nervous system neoplasm	0.000326	0.00156	CcSEcCtD
Nadolol—Chest pain—Alitretinoin—peripheral nervous system neoplasm	0.000324	0.00155	CcSEcCtD
Nadolol—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.000324	0.00155	CcSEcCtD
Nadolol—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.000324	0.00155	CcSEcCtD
Nadolol—Flatulence—Cisplatin—peripheral nervous system neoplasm	0.00032	0.00153	CcSEcCtD
Nadolol—Anorexia—Dactinomycin—peripheral nervous system neoplasm	0.00032	0.00153	CcSEcCtD
Nadolol—Dry mouth—Alitretinoin—peripheral nervous system neoplasm	0.000317	0.00152	CcSEcCtD
Nadolol—Hypertension—Vincristine—peripheral nervous system neoplasm	0.000317	0.00152	CcSEcCtD
Nadolol—Pulmonary oedema—Doxorubicin—peripheral nervous system neoplasm	0.000314	0.0015	CcSEcCtD
Nadolol—Oedema—Alitretinoin—peripheral nervous system neoplasm	0.000311	0.00149	CcSEcCtD
Nadolol—Vision blurred—Cisplatin—peripheral nervous system neoplasm	0.000306	0.00146	CcSEcCtD
Nadolol—Shock—Alitretinoin—peripheral nervous system neoplasm	0.000306	0.00146	CcSEcCtD
Nadolol—Cardiac failure congestive—Epirubicin—peripheral nervous system neoplasm	0.000305	0.00146	CcSEcCtD
Nadolol—Alopecia—Etoposide—peripheral nervous system neoplasm	0.000302	0.00144	CcSEcCtD
Nadolol—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.000301	0.00144	CcSEcCtD
Nadolol—Oedema—Vincristine—peripheral nervous system neoplasm	0.0003	0.00143	CcSEcCtD
Nadolol—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000297	0.00142	CcSEcCtD
Nadolol—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.000296	0.00142	CcSEcCtD
Nadolol—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000294	0.00141	CcSEcCtD
Nadolol—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000294	0.00141	CcSEcCtD
Nadolol—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000293	0.0014	CcSEcCtD
Nadolol—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.000292	0.00139	CcSEcCtD
Nadolol—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000291	0.00139	CcSEcCtD
Nadolol—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.000291	0.00139	CcSEcCtD
Nadolol—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.00029	0.00139	CcSEcCtD
Nadolol—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.00029	0.00139	CcSEcCtD
Nadolol—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.00029	0.00138	CcSEcCtD
Nadolol—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.000289	0.00138	CcSEcCtD
Nadolol—Pain—Dactinomycin—peripheral nervous system neoplasm	0.000287	0.00137	CcSEcCtD
Nadolol—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000287	0.00137	CcSEcCtD
Nadolol—Anorexia—Vincristine—peripheral nervous system neoplasm	0.000286	0.00137	CcSEcCtD
Nadolol—Cardiac failure—Epirubicin—peripheral nervous system neoplasm	0.000284	0.00136	CcSEcCtD
Nadolol—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000283	0.00135	CcSEcCtD
Nadolol—Lethargy—Epirubicin—peripheral nervous system neoplasm	0.000282	0.00135	CcSEcCtD
Nadolol—Cardiac failure congestive—Doxorubicin—peripheral nervous system neoplasm	0.000282	0.00135	CcSEcCtD
Nadolol—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.000281	0.00134	CcSEcCtD
Nadolol—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000281	0.00134	CcSEcCtD
Nadolol—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000281	0.00134	CcSEcCtD
Nadolol—Hypotension—Vincristine—peripheral nervous system neoplasm	0.00028	0.00134	CcSEcCtD
Nadolol—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.000279	0.00133	CcSEcCtD
Nadolol—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.000277	0.00133	CcSEcCtD
Nadolol—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000277	0.00132	CcSEcCtD
Nadolol—Diplopia—Epirubicin—peripheral nervous system neoplasm	0.000277	0.00132	CcSEcCtD
Nadolol—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000274	0.00131	CcSEcCtD
Nadolol—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000274	0.00131	CcSEcCtD
Nadolol—Affect lability—Epirubicin—peripheral nervous system neoplasm	0.000272	0.0013	CcSEcCtD
Nadolol—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000271	0.0013	CcSEcCtD
Nadolol—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000271	0.0013	CcSEcCtD
Nadolol—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000271	0.0013	CcSEcCtD
Nadolol—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.00027	0.00129	CcSEcCtD
Nadolol—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000269	0.00129	CcSEcCtD
Nadolol—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000268	0.00128	CcSEcCtD
Nadolol—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000266	0.00127	CcSEcCtD
Nadolol—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000266	0.00127	CcSEcCtD
Nadolol—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000265	0.00127	CcSEcCtD
Nadolol—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000265	0.00127	CcSEcCtD
Nadolol—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000263	0.00126	CcSEcCtD
Nadolol—Cardiac failure—Doxorubicin—peripheral nervous system neoplasm	0.000262	0.00125	CcSEcCtD
Nadolol—Mood swings—Epirubicin—peripheral nervous system neoplasm	0.000262	0.00125	CcSEcCtD
Nadolol—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.000261	0.00125	CcSEcCtD
Nadolol—Lethargy—Doxorubicin—peripheral nervous system neoplasm	0.000261	0.00125	CcSEcCtD
Nadolol—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000261	0.00125	CcSEcCtD
Nadolol—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000261	0.00125	CcSEcCtD
Nadolol—Rash—Topotecan—peripheral nervous system neoplasm	0.000261	0.00125	CcSEcCtD
Nadolol—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000261	0.00125	CcSEcCtD
Nadolol—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.00026	0.00125	CcSEcCtD
Nadolol—Cough—Etoposide—peripheral nervous system neoplasm	0.00026	0.00124	CcSEcCtD
Nadolol—Rash—Tretinoin—peripheral nervous system neoplasm	0.000259	0.00124	CcSEcCtD
Nadolol—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000259	0.00124	CcSEcCtD
Nadolol—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000258	0.00124	CcSEcCtD
Nadolol—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000258	0.00124	CcSEcCtD
Nadolol—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000258	0.00123	CcSEcCtD
Nadolol—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000258	0.00123	CcSEcCtD
Nadolol—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000257	0.00123	CcSEcCtD
Nadolol—Constipation—Vincristine—peripheral nervous system neoplasm	0.000256	0.00122	CcSEcCtD
Nadolol—Pain—Vincristine—peripheral nervous system neoplasm	0.000256	0.00122	CcSEcCtD
Nadolol—Diplopia—Doxorubicin—peripheral nervous system neoplasm	0.000256	0.00122	CcSEcCtD
Nadolol—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000256	0.00122	CcSEcCtD
Nadolol—Rash—Melphalan—peripheral nervous system neoplasm	0.000255	0.00122	CcSEcCtD
Nadolol—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000255	0.00122	CcSEcCtD
Nadolol—Dry skin—Epirubicin—peripheral nervous system neoplasm	0.000254	0.00121	CcSEcCtD
Nadolol—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000253	0.00121	CcSEcCtD
Nadolol—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000253	0.00121	CcSEcCtD
Nadolol—Affect lability—Doxorubicin—peripheral nervous system neoplasm	0.000252	0.00121	CcSEcCtD
Nadolol—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000248	0.00118	CcSEcCtD
Nadolol—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000246	0.00118	CcSEcCtD
Nadolol—Nausea—Topotecan—peripheral nervous system neoplasm	0.000246	0.00117	CcSEcCtD
Nadolol—Gastritis—Epirubicin—peripheral nervous system neoplasm	0.000245	0.00117	CcSEcCtD
Nadolol—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000244	0.00117	CcSEcCtD
Nadolol—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000244	0.00117	CcSEcCtD
Nadolol—Mood swings—Doxorubicin—peripheral nervous system neoplasm	0.000243	0.00116	CcSEcCtD
Nadolol—Abdominal distension—Epirubicin—peripheral nervous system neoplasm	0.000241	0.00115	CcSEcCtD
Nadolol—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000241	0.00115	CcSEcCtD
Nadolol—Nausea—Melphalan—peripheral nervous system neoplasm	0.000241	0.00115	CcSEcCtD
Nadolol—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000238	0.00114	CcSEcCtD
Nadolol—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000237	0.00113	CcSEcCtD
Nadolol—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000236	0.00113	CcSEcCtD
Nadolol—Dry skin—Doxorubicin—peripheral nervous system neoplasm	0.000235	0.00112	CcSEcCtD
Nadolol—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000235	0.00112	CcSEcCtD
Nadolol—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000231	0.00111	CcSEcCtD
Nadolol—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.00023	0.0011	CcSEcCtD
Nadolol—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000229	0.0011	CcSEcCtD
Nadolol—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000227	0.00108	CcSEcCtD
Nadolol—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.000227	0.00108	CcSEcCtD
Nadolol—Pain—Cisplatin—peripheral nervous system neoplasm	0.000227	0.00108	CcSEcCtD
Nadolol—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000223	0.00107	CcSEcCtD
Nadolol—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.000223	0.00107	CcSEcCtD
Nadolol—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.00022	0.00105	CcSEcCtD
Nadolol—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000218	0.00104	CcSEcCtD
Nadolol—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000218	0.00104	CcSEcCtD
Nadolol—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000216	0.00103	CcSEcCtD
Nadolol—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000215	0.00103	CcSEcCtD
Nadolol—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000213	0.00102	CcSEcCtD
Nadolol—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000213	0.00102	CcSEcCtD
Nadolol—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000211	0.00101	CcSEcCtD
Nadolol—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000211	0.00101	CcSEcCtD
Nadolol—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000209	0.001	CcSEcCtD
Nadolol—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000209	0.001	CcSEcCtD
Nadolol—Constipation—Etoposide—peripheral nervous system neoplasm	0.000208	0.000992	CcSEcCtD
Nadolol—Pain—Etoposide—peripheral nervous system neoplasm	0.000208	0.000992	CcSEcCtD
Nadolol—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000207	0.000991	CcSEcCtD
Nadolol—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000206	0.000983	CcSEcCtD
Nadolol—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000205	0.00098	CcSEcCtD
Nadolol—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000205	0.000978	CcSEcCtD
Nadolol—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000201	0.000963	CcSEcCtD
Nadolol—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000199	0.000952	CcSEcCtD
Nadolol—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000199	0.000952	CcSEcCtD
Nadolol—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000198	0.000947	CcSEcCtD
Nadolol—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000198	0.000945	CcSEcCtD
Nadolol—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000196	0.000937	CcSEcCtD
Nadolol—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000196	0.000936	CcSEcCtD
Nadolol—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000195	0.000932	CcSEcCtD
Nadolol—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000192	0.000917	CcSEcCtD
Nadolol—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000192	0.000917	CcSEcCtD
Nadolol—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000191	0.000911	CcSEcCtD
Nadolol—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.00019	0.000909	CcSEcCtD
Nadolol—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000189	0.000905	CcSEcCtD
Nadolol—Rash—Vincristine—peripheral nervous system neoplasm	0.000189	0.000903	CcSEcCtD
Nadolol—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000189	0.000902	CcSEcCtD
Nadolol—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000185	0.000883	CcSEcCtD
Nadolol—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000185	0.000882	CcSEcCtD
Nadolol—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000184	0.000881	CcSEcCtD
Nadolol—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000181	0.000867	CcSEcCtD
Nadolol—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.00018	0.000862	CcSEcCtD
Nadolol—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000179	0.000854	CcSEcCtD
Nadolol—Nausea—Vincristine—peripheral nervous system neoplasm	0.000178	0.000851	CcSEcCtD
Nadolol—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000174	0.000833	CcSEcCtD
Nadolol—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000172	0.000821	CcSEcCtD
Nadolol—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000171	0.000816	CcSEcCtD
Nadolol—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000169	0.000809	CcSEcCtD
Nadolol—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000168	0.000805	CcSEcCtD
Nadolol—Rash—Cisplatin—peripheral nervous system neoplasm	0.000167	0.000799	CcSEcCtD
Nadolol—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000167	0.000798	CcSEcCtD
Nadolol—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000166	0.000794	CcSEcCtD
Nadolol—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000165	0.00079	CcSEcCtD
Nadolol—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000164	0.000785	CcSEcCtD
Nadolol—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000161	0.000767	CcSEcCtD
Nadolol—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000157	0.000752	CcSEcCtD
Nadolol—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000157	0.000751	CcSEcCtD
Nadolol—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000157	0.000749	CcSEcCtD
Nadolol—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000154	0.000738	CcSEcCtD
Nadolol—Rash—Etoposide—peripheral nervous system neoplasm	0.000153	0.000732	CcSEcCtD
Nadolol—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000153	0.000731	CcSEcCtD
Nadolol—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000152	0.000727	CcSEcCtD
Nadolol—Syncope—Epirubicin—peripheral nervous system neoplasm	0.00015	0.000715	CcSEcCtD
Nadolol—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000147	0.0007	CcSEcCtD
Nadolol—Cough—Epirubicin—peripheral nervous system neoplasm	0.000145	0.000695	CcSEcCtD
Nadolol—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000145	0.000695	CcSEcCtD
Nadolol—Nausea—Etoposide—peripheral nervous system neoplasm	0.000144	0.000689	CcSEcCtD
Nadolol—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000144	0.000688	CcSEcCtD
Nadolol—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000142	0.000679	CcSEcCtD
Nadolol—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000139	0.000664	CcSEcCtD
Nadolol—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.000661	CcSEcCtD
Nadolol—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000136	0.00065	CcSEcCtD
Nadolol—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000136	0.000648	CcSEcCtD
Nadolol—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000135	0.000643	CcSEcCtD
Nadolol—Shock—Epirubicin—peripheral nervous system neoplasm	0.000134	0.00064	CcSEcCtD
Nadolol—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000133	0.000637	CcSEcCtD
Nadolol—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000132	0.000629	CcSEcCtD
Nadolol—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.000628	CcSEcCtD
Nadolol—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.00013	0.00062	CcSEcCtD
Nadolol—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000128	0.000614	CcSEcCtD
Nadolol—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000608	CcSEcCtD
Nadolol—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000602	CcSEcCtD
Nadolol—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.000592	CcSEcCtD
Nadolol—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000123	0.000588	CcSEcCtD
Nadolol—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000122	0.000584	CcSEcCtD
Nadolol—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.000582	CcSEcCtD
Nadolol—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000121	0.00058	CcSEcCtD
Nadolol—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.00012	0.000574	CcSEcCtD
Nadolol—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.00012	0.000573	CcSEcCtD
Nadolol—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000118	0.000565	CcSEcCtD
Nadolol—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000562	CcSEcCtD
Nadolol—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000561	CcSEcCtD
Nadolol—Pain—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000556	CcSEcCtD
Nadolol—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000556	CcSEcCtD
Nadolol—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.000544	CcSEcCtD
Nadolol—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.00054	CcSEcCtD
Nadolol—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000537	CcSEcCtD
Nadolol—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000111	0.00053	CcSEcCtD
Nadolol—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000523	CcSEcCtD
Nadolol—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000519	CcSEcCtD
Nadolol—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000515	CcSEcCtD
Nadolol—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000515	CcSEcCtD
Nadolol—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000514	CcSEcCtD
Nadolol—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	9.95e-05	0.000476	CcSEcCtD
Nadolol—Asthenia—Epirubicin—peripheral nervous system neoplasm	9.76e-05	0.000467	CcSEcCtD
Nadolol—Pruritus—Epirubicin—peripheral nervous system neoplasm	9.63e-05	0.00046	CcSEcCtD
Nadolol—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	9.31e-05	0.000445	CcSEcCtD
Nadolol—Asthenia—Doxorubicin—peripheral nervous system neoplasm	9.03e-05	0.000432	CcSEcCtD
Nadolol—Dizziness—Epirubicin—peripheral nervous system neoplasm	9e-05	0.00043	CcSEcCtD
Nadolol—Pruritus—Doxorubicin—peripheral nervous system neoplasm	8.91e-05	0.000426	CcSEcCtD
Nadolol—Vomiting—Epirubicin—peripheral nervous system neoplasm	8.65e-05	0.000414	CcSEcCtD
Nadolol—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	8.61e-05	0.000412	CcSEcCtD
Nadolol—Rash—Epirubicin—peripheral nervous system neoplasm	8.58e-05	0.00041	CcSEcCtD
Nadolol—Dermatitis—Epirubicin—peripheral nervous system neoplasm	8.57e-05	0.00041	CcSEcCtD
Nadolol—Dizziness—Doxorubicin—peripheral nervous system neoplasm	8.33e-05	0.000398	CcSEcCtD
Nadolol—Nausea—Epirubicin—peripheral nervous system neoplasm	8.08e-05	0.000386	CcSEcCtD
Nadolol—Vomiting—Doxorubicin—peripheral nervous system neoplasm	8e-05	0.000383	CcSEcCtD
Nadolol—Rash—Doxorubicin—peripheral nervous system neoplasm	7.94e-05	0.000379	CcSEcCtD
Nadolol—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	7.93e-05	0.000379	CcSEcCtD
Nadolol—Nausea—Doxorubicin—peripheral nervous system neoplasm	7.48e-05	0.000357	CcSEcCtD
